Addus HomeCare (NASDAQ:ADUS) Stock: Insider R Dirk Allison Sells 98,958 Shares

Addus HomeCare logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • CEO R. Dirk Allison sold 98,958 shares at an average of $123.27, for about $12.2 million, reducing his direct stake by 35.08% to 183,150 shares.
  • Addus HomeCare reported quarterly EPS of $1.83, beating the $1.79 consensus, while revenue rose 7% year over year to $387.74 million—slightly below analyst estimates.
  • Analysts’ consensus rating is Moderate Buy, with an average price target of $134.70; shares traded at $126.29 after rising $3.87.
  • Five stocks we like better than Addus HomeCare.

Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) CEO R. Allison sold 98,958 shares of the business's stock in a transaction on Monday, November 9th. The shares were sold at an average price of $123.27, for a total transaction of $12,198,552.66. Following the transaction, the chief executive officer directly owned 183,150 shares of the company's stock, valued at approximately $22,576,900.50. This trade represents a 35.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Addus HomeCare Stock Performance

Shares of ADUS stock traded up $3.87 during trading hours on Tuesday, reaching $126.29. The stock had a trading volume of 225,844 shares, compared to its average volume of 237,872. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.69. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $131.59. The firm has a 50-day simple moving average of $117.74 and a 200-day simple moving average of $106.95. The firm has a market capitalization of $2.36 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. During the same period in the previous year, the business posted $1.56 EPS. Addus HomeCare's revenue was up 7.0% on a year-over-year basis. As a group, equities analysts forecast that Addus HomeCare Corporation will post 6.34 earnings per share for the current year.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Addus HomeCare in the 2nd quarter worth $344,153,000. Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 11.8% during the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company's stock worth $69,689,000 after acquiring an additional 78,415 shares during the period. Bank of America Corp DE acquired a new position in Addus HomeCare during the second quarter worth about $35,527,000. TimesSquare Capital Management LLC bought a new stake in Addus HomeCare in the second quarter worth about $31,502,000. Finally, Allspring Global Investments Holdings LLC raised its position in Addus HomeCare by 110.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 189,718 shares of the company's stock worth $21,192,000 after acquiring an additional 99,596 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on ADUS shares. Barclays raised their target price on Addus HomeCare from $96.00 to $101.00 and gave the company an "underweight" rating in a research report on Wednesday, November 4th. Truist Financial increased their price target on Addus HomeCare from $135.00 to $148.00 and gave the stock a "buy" rating in a research note on Thursday, November 5th. Royal Bank Of Canada raised their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a report on Wednesday, August 5th. Citigroup lowered shares of Addus HomeCare from a "market outperform" rating to a "neutral" rating in a research report on Monday, September 14th. Finally, Weiss Ratings raised shares of Addus HomeCare from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, September 24th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Addus HomeCare has an average rating of "Moderate Buy" and an average target price of $134.70.

Check Out Our Latest Report on Addus HomeCare

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Read More

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines